NUIG researchers leading trial on potentially fatal multiple myeloma

Irish patients with blood cancer are the first worldwide to take part in a new drug trial to develop more effective treatment for multiple myeloma, a potentially fatal condition.

Researchers at NUI Galway are carrying out the clinical trial for patients who will be treated with a new combination of drugs that is hoped will save lives.

Each year in Ireland, about 250 people are diagnosed with multiple myeloma and 170 die from the disease.